These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36278940)

  • 1. Large-Scale Synthesis of Man
    Neralkar M; Xu B; Horiya S; Krauss IJ
    ACS Infect Dis; 2022 Nov; 8(11):2232-2241. PubMed ID: 36278940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High temperature SELMA: evolution of DNA-supported oligomannose clusters which are tightly recognized by HIV bnAb 2G12.
    Temme JS; MacPherson IS; DeCourcey JF; Krauss IJ
    J Am Chem Soc; 2014 Feb; 136(5):1726-9. PubMed ID: 24446826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of high-mannose-type oligosaccharides and synthetic oligomannose clusters to human antibody 2G12: implications for HIV-1 vaccine design.
    Wang LX; Ni J; Singh S; Li H
    Chem Biol; 2004 Jan; 11(1):127-34. PubMed ID: 15113002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates.
    Saunders KO; Nicely NI; Wiehe K; Bonsignori M; Meyerhoff RR; Parks R; Walkowicz WE; Aussedat B; Wu NR; Cai F; Vohra Y; Park PK; Eaton A; Go EP; Sutherland LL; Scearce RM; Barouch DH; Zhang R; Von Holle T; Overman RG; Anasti K; Sanders RW; Moody MA; Kepler TB; Korber B; Desaire H; Santra S; Letvin NL; Nabel GJ; Montefiori DC; Tomaras GD; Liao HX; Alam SM; Danishefsky SJ; Haynes BF
    Cell Rep; 2017 Feb; 18(9):2175-2188. PubMed ID: 28249163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An engineered Saccharomyces cerevisiae strain binds the broadly neutralizing human immunodeficiency virus type 1 antibody 2G12 and elicits mannose-specific gp120-binding antibodies.
    Luallen RJ; Lin J; Fu H; Cai KK; Agrawal C; Mboudjeka I; Lee FH; Montefiori D; Smith DF; Doms RW; Geng Y
    J Virol; 2008 Jul; 82(13):6447-57. PubMed ID: 18434410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody 2G12 recognizes di-mannose equivalently in domain- and nondomain-exchanged forms but only binds the HIV-1 glycan shield if domain exchanged.
    Doores KJ; Fulton Z; Huber M; Wilson IA; Burton DR
    J Virol; 2010 Oct; 84(20):10690-9. PubMed ID: 20702629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel template-assembled oligosaccharide clusters as epitope mimics for HIV-neutralizing antibody 2G12. Design, synthesis, and antibody binding study.
    Wang J; Li H; Zou G; Wang LX
    Org Biomol Chem; 2007 May; 5(10):1529-40. PubMed ID: 17571181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind to the self glycans of gp120.
    Astronomo RD; Lee HK; Scanlan CN; Pantophlet R; Huang CY; Wilson IA; Blixt O; Dwek RA; Wong CH; Burton DR
    J Virol; 2008 Jul; 82(13):6359-68. PubMed ID: 18434393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategies.
    Doores KJ; Huber M; Le KM; Wang SK; Doyle-Cooper C; Cooper A; Pantophlet R; Wong CH; Nemazee D; Burton DR
    J Virol; 2013 Feb; 87(4):2234-41. PubMed ID: 23221565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody responses to the HIV-1 envelope high mannose patch.
    Daniels CN; Saunders KO
    Adv Immunol; 2019; 143():11-73. PubMed ID: 31607367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies elicited by yeast glycoproteins recognize HIV-1 virions and potently neutralize virions with high mannose N-glycans.
    Zhang H; Fu H; Luallen RJ; Liu B; Lee FH; Doms RW; Geng Y
    Vaccine; 2015 Sep; 33(39):5140-7. PubMed ID: 26277072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN.
    Wang SK; Liang PH; Astronomo RD; Hsu TL; Hsieh SL; Burton DR; Wong CH
    Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3690-5. PubMed ID: 18310320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12.
    Pashov A; MacLeod S; Saha R; Perry M; VanCott TC; Kieber-Emmons T
    Glycobiology; 2005 Oct; 15(10):994-1001. PubMed ID: 15917430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans.
    Dunlop DC; Bonomelli C; Mansab F; Vasiljevic S; Doores KJ; Wormald MR; Palma AS; Feizi T; Harvey DJ; Dwek RA; Crispin M; Scanlan CN
    Glycobiology; 2010 Jul; 20(7):812-23. PubMed ID: 20181792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assembling different antennas of the gp120 high mannose-type glycans on gold nanoparticles provides superior binding to the anti-HIV antibody 2G12 than the individual antennas.
    Chiodo F; Enríquez-Navas PM; Angulo J; Marradi M; Penadés S
    Carbohydr Res; 2015 Mar; 405():102-9. PubMed ID: 25573666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining criteria for oligomannose immunogens for HIV using icosahedral virus capsid scaffolds.
    Astronomo RD; Kaltgrad E; Udit AK; Wang SK; Doores KJ; Huang CY; Pantophlet R; Paulson JC; Wong CH; Finn MG; Burton DR
    Chem Biol; 2010 Apr; 17(4):357-70. PubMed ID: 20416507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression, glycoform characterization, and antibody-binding of HIV-1 V3 glycopeptide domain fused with human IgG1-Fc.
    Yang Q; Li C; Wei Y; Huang W; Wang LX
    Bioconjug Chem; 2010 May; 21(5):875-83. PubMed ID: 20369886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A yeast glycoprotein shows high-affinity binding to the broadly neutralizing human immunodeficiency virus antibody 2G12 and inhibits gp120 interactions with 2G12 and DC-SIGN.
    Luallen RJ; Fu H; Agrawal-Gamse C; Mboudjeka I; Huang W; Lee FH; Wang LX; Doms RW; Geng Y
    J Virol; 2009 May; 83(10):4861-70. PubMed ID: 19264785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.
    Scanlan CN; Pantophlet R; Wormald MR; Ollmann Saphire E; Stanfield R; Wilson IA; Katinger H; Dwek RA; Rudd PM; Burton DR
    J Virol; 2002 Jul; 76(14):7306-21. PubMed ID: 12072529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12.
    Calarese DA; Lee HK; Huang CY; Best MD; Astronomo RD; Stanfield RL; Katinger H; Burton DR; Wong CH; Wilson IA
    Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13372-7. PubMed ID: 16174734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.